Primary Prevention Benefits and Risks of oral Anticoagulation with Dabigatran or Warfarin

被引：0
|
作者：
Diener, H. C.
机构：
来源：
AKTUELLE NEUROLOGIE | 2015年 / 42卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：E53 / E53
页数：1
相关论文
共 50 条
  • [41] Translational insights into traumatic brain injury occurring during dabigatran or warfarin anticoagulation
    Schaefer, Jan Hendrik
    Leung, Wendy
    Wu, Limin
    Van Cott, Elizabeth M.
    Lok, Josephine
    Whalen, Michael
    van Leyen, Klaus
    Lauer, Arne
    van Ryn, Joanne
    Lo, Eng H.
    Foerch, Christian
    JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM, 2014, 34 (05): : 870 - 875
  • [42] Primary and secondary stroke prevention in nonrheumatic atrial fibrillation by oral anticoagulation
    Stöllberger, C
    Finsterer, J
    EUROPEAN NEUROLOGY, 2003, 50 (03) : 127 - 135
  • [43] Benefits and Risks of Anticoagulation in Acute Coronary Syndrome
    Pop, Calin
    Matei, Claudia
    AMERICAN JOURNAL OF THERAPEUTICS, 2019, 26 (02) : E198 - E207
  • [44] Risks and Benefits of Anticoagulation in Cancer and Noncancer Patients
    Park, Deborah Y.
    Khorana, Alok A.
    SEMINARS IN THROMBOSIS AND HEMOSTASIS, 2019, 45 (06): : 629 - 637
  • [45] Bleeding Risks minimize by oral Anticoagulation
    不详
    MEDIZINISCHE KLINIK-INTENSIVMEDIZIN UND NOTFALLMEDIZIN, 2017, 112 (01) : 2 - 2
  • [46] Oral anticoagulation and prevention of bleeding
    Madsen, Steinar
    Werner, Bente
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2006, 15 : S102 - S103
  • [47] COST EFFECTIVENESS OF ORAL ANTICOAGULATION THERAPY FOR NON-VALVULAR ATRIAL FIBRILLATION PATIENTS: WARFARIN VERSUS THE NEW ORAL ANTICOAGULANTS RIVAROXABAN, DABIGATRAN AND APIXABAN
    Ortiz-Cartagena, Ismael
    Gotay, Antonio Orraca
    Acevedo, Jose
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2018, 71 (11) : 490 - 490
  • [48] Primary prevention PVI for atrial fibrillation-Weighing the risks and benefits
    Gula, Lorne J.
    Leong-Sit, Peter
    Skanes, Allan C.
    HEART RHYTHM, 2014, 11 (09) : 1573 - 1574
  • [49] Aspirin in the primary prevention of cardiovascular diseases: how to balance risks and benefits
    De Caterina, Raffaele
    Orlando, Donatella
    Berti, Valentina
    Coccheri, Sergio
    GIORNALE ITALIANO DI CARDIOLOGIA, 2012, 13 (07) : 494 - 502
  • [50] Warfarin embryopathy: Balancing maternal and fetal risks with anticoagulation therapy
    Ferreira, Sara
    Costa, Raquel
    Malveiro, Duarte
    Vieira, Filipa
    Tuna, Madalena
    PEDIATRICS AND NEONATOLOGY, 2018, 59 (05): : 534 - 535
12345